Former fighter pilot Tim Kelly named Caribou CTO

8 January 2024

CRISPR genome-editing company Caribou Biosciences (Nasdaq: CRBU) has appointed Tim Kelly to the newly-created position of chief technology officer.

Mr Kelly has more than 25 years of experience in global clinical and commercial product development, manufacturing and supply chain operations with large and small biopharma and cell and gene therapy companies in the USA and Europe.

The appointment comes after a year in which Caribou made progress across its allogeneic CAR-T cell therapy platform, with multiple clinical catalysts planned for 2024.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK